Processa Pharmaceuticals Inc (PCSA)
Processa Pharmaceuticals Market Cap: 5.602M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 5.602M |
May 16, 2024 | 5.716M |
May 15, 2024 | 5.773M |
May 14, 2024 | 6.230M |
May 13, 2024 | 6.345M |
May 10, 2024 | 5.973M |
May 09, 2024 | 6.087M |
May 08, 2024 | 7.088M |
May 07, 2024 | 7.088M |
May 06, 2024 | 6.716M |
May 03, 2024 | 6.202M |
May 02, 2024 | 6.459M |
May 01, 2024 | 6.344M |
April 30, 2024 | 6.230M |
April 29, 2024 | 6.002M |
April 26, 2024 | 6.141M |
April 25, 2024 | 6.940M |
April 24, 2024 | 4.627M |
April 23, 2024 | 4.570M |
April 22, 2024 | 4.370M |
April 19, 2024 | 4.512M |
April 18, 2024 | 4.455M |
April 17, 2024 | 4.741M |
April 16, 2024 | 4.398M |
April 15, 2024 | 4.327M |
Date | Value |
---|---|
April 12, 2024 | 4.770M |
April 11, 2024 | 5.027M |
April 10, 2024 | 5.255M |
April 09, 2024 | 8.311M |
April 08, 2024 | 8.525M |
April 05, 2024 | 7.968M |
April 04, 2024 | 6.626M |
April 03, 2024 | 6.740M |
April 02, 2024 | 7.254M |
April 01, 2024 | 6.712M |
March 28, 2024 | 6.754M |
March 27, 2024 | 6.483M |
March 26, 2024 | 6.198M |
March 25, 2024 | 6.426M |
March 22, 2024 | 6.397M |
March 21, 2024 | 6.198M |
March 20, 2024 | 3.808M |
March 19, 2024 | 3.859M |
March 18, 2024 | 3.911M |
March 15, 2024 | 3.740M |
March 14, 2024 | 3.808M |
March 13, 2024 | 3.911M |
March 12, 2024 | 3.876M |
March 11, 2024 | 3.894M |
March 08, 2024 | 3.876M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
DIH Holding US Inc | 65.68M |
NovaBay Pharmaceuticals Inc | 4.487M |
Palatin Technologies Inc | 32.27M |
iBio Inc | 6.899M |
Theriva Biologics Inc | 6.405M |
Market Cap Related Metrics
Price to Book Value | 0.6306 |
Price | 1.93 |
Earnings Yield | -326.0% |